BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Compounds That Target ADCK1

AarF domain-containing protein kinase 1 · 16 compounds in BiohacksAI corpus

ADCK1 (AarF domain-containing protein kinase 1) is a biological target with 16 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into ADCK1 modulation for therapeutic and biohacking applications.

All 16 Compounds — Ranked by Evidence
1
Pazopanib
3.69
confidence
2
Abemaciclib
3.66
confidence
3
Fedratinib
3.40
confidence
4
Gilteritinib
3.40
confidence
5
At 9283
3.09
confidence
6
Pacritinib
3.04
confidence
7
Filgotinib
3.04
confidence
8
Adavosertib
3.04
confidence
9
Momelotinib
2.89
confidence
10
R 406
2.83
confidence
11
K 252a
2.83
confidence
12
Zotiraciclib
2.56
confidence
13
Gsk 1070916
2.20
confidence
14
Cyc 116
2.08
confidence
15
Fostamatinib
2.08
confidence
16
Osi 632
1.79
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for ADCK1 (AarF domain-containing protein kinase 1). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: ADCK1 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.